Breaking News

Evonik Unveils EUDRACAP Oral Capsule for Preclinical Trials

Enables pharma companies to optimize drug development by reducing cost, time, and variables during preclinical trials.

Evonik, a CDMO for complex oral and parenteral drug products requiring advanced drug delivery solutions, launched EUDRACAP, a functional, ready-to-fill oral capsule designed for use in preclinical trials. EUDRACAP preclinic enteric is a very small size 9h (5.1 mm), technical-grade capsule suitable for passing through the gastrointestinal tract of preclinical animal models. The enteric-coated capsule aims to enable pharmaceutical companies to optimize drug development by reducing cost, time, and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters